Abu Sammour, D., Marsching, C., Geisel, A., Erich, K., Schulz, S., Ramallo Guevara, C., . . . Hopf, C. (2019). Quantitative mass spectrometry imaging reveals mutation status-independent lack of imatinib in liver metastases of gastrointestinal stromal tumors. Scientific reports, 9, . https://doi.org/10.1038/s41598-019-47089-5
Chicago Style (17th ed.) CitationAbu Sammour, Denis, et al. "Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors." Scientific Reports 9 (2019). https://doi.org/10.1038/s41598-019-47089-5.
MLA (9th ed.) CitationAbu Sammour, Denis, et al. "Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors." Scientific Reports, vol. 9, 2019, https://doi.org/10.1038/s41598-019-47089-5.